跳至主要内容
临床试验/EUCTR2007-004734-17-FI
EUCTR2007-004734-17-FI进行中(未招募)不适用

A double-blind, randomized, placebo-controlled study of early oseltamivir treatment of influenza in children 1-3 years of age

Terho Heikkinen0 个研究点开始时间: 2007年9月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
Terho Heikkinen

相似试验

进行中(未招募)
1 期
A study of UCB0942 in adult patients with highly drug-resistant focal epilepsy
EUCTR2014-003330-12-HUCB Biopharma SPR46
进行中(未招募)
1 期
A study of UCB0942 in adult patients with highly drug-resistant focal epilepsyhighly drug-resistant focal epilepsyMedDRA version: 21.1Level: LLTClassification code 10065337Term: Focal epilepsySystem Organ Class: 100000004852
EUCTR2014-003330-12-ITCB Biopharma SR55
招募中
1 期
Safety and efficacy of PC945 in combination with other antifungal therapy for the treatment of refractory invasive pulmonary aspergillosis (Opera-T Study)Refractory invasive pulmonary aspergillosis (IPA)MedDRA version: 20.0Level: LLTClassification code 10059259Term: Pulmonary aspergillosisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2021-004554-32-ATPulmocide Ltd123
已完成
3 期
A double-blind, randomized, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P, CBD) as add-on therapy in patients with tuberous sclerosis complex who experience inadequately-controlled seizures
NL-OMON47292GW Research Ltd25
已完成
不适用
A double-blind, randomized, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending oral doses of ASP2905 in healthy young males, including an open-label two-period randomized crossover study to compare the pharmacokinetics under fasted and fed conditionsziekte van Alzheimer, schizofrenieAlzheimer's Disease and schizophreny
NL-OMON32022Astellas Pharma68